{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:13:14Z","timestamp":1793779994302,"version":"4.6.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77320-7","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:03:14Z","timestamp":1789722194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma"],"prefix":"10.1038","volume":"17","author":[{"given":"Felipe J.","family":"N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzar A.","family":"Mujeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Mauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Tronrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9153","authenticated-orcid":false,"given":"Ziwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhakshi","family":"Raghuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya R.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Armando","family":"Pena Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Zelaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Kadiyala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Garcia-Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-5753","authenticated-orcid":false,"given":"Andrea","family":"Comba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Alghamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon L.","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5588-900X","authenticated-orcid":false,"given":"Adam","family":"Klaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-2045","authenticated-orcid":false,"given":"Zeribe C.","family":"Nwosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-7481","authenticated-orcid":false,"given":"Peter","family":"Sajjakulnukit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-5702","authenticated-orcid":false,"given":"Maureen A.","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1553-6695","authenticated-orcid":false,"given":"Mats","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-2391","authenticated-orcid":false,"given":"Joshua D.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-0588","authenticated-orcid":false,"given":"Shi-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-4409","authenticated-orcid":false,"given":"Pedro R.","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3334-2053","authenticated-orcid":false,"given":"Joerg","family":"Lahann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-2756","authenticated-orcid":false,"given":"Maria G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"77320_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller, M. et al. Glioma. Nat. Rev. Dis. Prim. 1, 15017 https:\/\/doi.org\/10.1038\/nrdp.2015.17 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"77320_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"Ceccarelli","year":"2016","unstructured":"Ceccarelli et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550\u2013563 https:\/\/doi.org\/10.1016\/j.cell.2015.12.028 (2016).","journal-title":"Cell"},{"key":"77320_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 131, 803\u2013820 https:\/\/doi.org\/10.1007\/s00401-016-1545-1 (2016).","journal-title":"Acta Neuropathol."},{"key":"77320_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat, D. J. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481\u20132498 https:\/\/doi.org\/10.1056\/NEJMoa1402121 (2015). From NLM.","journal-title":"N. Engl. J. Med."},{"key":"77320_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744 https:\/\/doi.org\/10.1038\/nature08617 (2009).","journal-title":"Nature"},{"key":"77320_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41568-020-00303-3","volume":"20","author":"J-A Losman","year":"2020","unstructured":"Losman, J.-A., Koivunen, P. & Kaelin, W. G. 2-Oxoglutarate-dependent dioxygenases in cancer. Nat. Rev. Cancer 20, 710\u2013726 https:\/\/doi.org\/10.1038\/s41568-020-00303-3 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"77320_CR7","doi-asserted-by":"publisher","unstructured":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481\u20132498 https:\/\/doi.org\/10.1056\/NEJMoa1402121 (2015).","DOI":"10.1056\/NEJMoa1402121"},{"key":"77320_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812, https:\/\/doi.org\/10.1126\/science.1164382 (2008).","journal-title":"Science"},{"key":"77320_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1236062","volume":"340","author":"D Rohle","year":"2013","unstructured":"Rohle, D. et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340, 626\u2013630 https:\/\/doi.org\/10.1126\/science.1236062 (2013).","journal-title":"Science"},{"key":"77320_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/neuonc\/nou027","volume":"16","author":"AL Baldock","year":"2014","unstructured":"Baldock, A. L. et al. Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro Oncol. 16, 779\u2013786 https:\/\/doi.org\/10.1093\/neuonc\/nou027 (2014).","journal-title":"Neuro Oncol."},{"key":"77320_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1101\/gad.294991.116","volume":"31","author":"NM Amankulor","year":"2017","unstructured":"Amankulor, N. M. et al. Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev. 31, 774\u2013786 https:\/\/doi.org\/10.1101\/gad.294991.116 (2017).","journal-title":"Genes Dev."},{"key":"77320_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh3243","volume":"7","author":"MS Alghamri","year":"2021","unstructured":"Alghamri, M. S. et al. G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy. Sci. Adv. 7, eabh3243 https:\/\/doi.org\/10.1126\/sciadv.abh3243 (2021).","journal-title":"Sci. Adv."},{"key":"77320_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","volume":"592","author":"M Platten","year":"2021","unstructured":"Platten, M. et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature 592, 463\u2013468 https:\/\/doi.org\/10.1038\/s41586-021-03363-z (2021).","journal-title":"Nature"},{"key":"77320_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-013-1194-6","volume":"127","author":"MR Gilbert","year":"2014","unstructured":"Gilbert, M. R. et al. Autophagy and oxidative stress in gliomas with IDH1 mutations. Acta Neuropathol. 127, 221\u2013233 https:\/\/doi.org\/10.1007\/s00401-013-1194-6 (2014).","journal-title":"Acta Neuropathol."},{"key":"77320_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1427","volume":"11","author":"FJ N\u00fa\u00f1ez","year":"2019","unstructured":"N\u00fa\u00f1ez, F. J. et al. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Sci. Transl. Med. 11, eaaq1427 https:\/\/doi.org\/10.1126\/scitranslmed.aaq1427 (2019).","journal-title":"Sci. Transl. Med."},{"key":"77320_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40170-018-0177-4","volume":"6","author":"M Garrett","year":"2018","unstructured":"Garrett, M. et al. Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities. Cancer Metab. 6, 4 https:\/\/doi.org\/10.1186\/s40170-018-0177-4 (2018).","journal-title":"Cancer Metab."},{"key":"77320_CR17","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1158\/0008-5472.CAN-14-0924","volume":"74","author":"S Ohba","year":"2014","unstructured":"Ohba, S., Mukherjee, J., See, W. L. & Pieper, R. O. Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. Cancer Res. 74, 4836\u20134844 https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0924 (2014).","journal-title":"Cancer Res."},{"key":"77320_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/1078-0432.Ccr-22-1896","volume":"29","author":"SV Carney","year":"2023","unstructured":"Carney, S. V. et al. Zinc finger MYND-type containing 8 (ZMYND8) Is epigenetically regulated in mutant isocitrate dehydrogenase 1 (IDH1) glioma to promote radioresistance. Clin. Cancer Res 29, 1763\u20131782 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-1896 (2023).","journal-title":"Clin. Cancer Res"},{"key":"77320_CR19","doi-asserted-by":"publisher","first-page":"23318","DOI":"10.1074\/jbc.M114.575183","volume":"289","author":"ZJ Reitman","year":"2014","unstructured":"Reitman, Z. J. et al. Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia*. J. Biol. Chem. 289, 23318\u201323328 https:\/\/doi.org\/10.1074\/jbc.M114.575183 (2014).","journal-title":"J. Biol. Chem."},{"key":"77320_CR20","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-15-0840","volume":"75","author":"JL Izquierdo-Garcia","year":"2015","unstructured":"Izquierdo-Garcia, J. L. et al. IDH1 mutation induces reprogramming of pyruvate metabolism. Cancer Res. 75, 2999\u20133009 https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0840 (2015).","journal-title":"Cancer Res."},{"key":"77320_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/0008-5472.CAN-17-1352","volume":"78","author":"MS Waitkus","year":"2018","unstructured":"Waitkus, M. S. et al. Adaptive evolution of the GDH2 allosteric domain promotes gliomagenesis by resolving IDH1R132H-induced metabolic liabilities. Cancer Res. 78, 36\u201350 https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1352 (2018).","journal-title":"Cancer Res."},{"key":"77320_CR22","doi-asserted-by":"publisher","unstructured":"Kadiyala, P. et al. Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI139542 (2021).","DOI":"10.1172\/JCI139542"},{"key":"77320_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46217-5","volume":"9","author":"S Miyata","year":"2019","unstructured":"Miyata, S. et al. Comprehensive metabolomic analysis of IDH1R132H clinical glioma samples reveals suppression of \u03b2-oxidation due to carnitine deficiency. Sci. Rep. 9, 9787 https:\/\/doi.org\/10.1038\/s41598-019-46217-5 (2019).","journal-title":"Sci. Rep."},{"key":"77320_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1021\/acs.jproteome.8b00663","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou, L. et al. Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation. J. Proteome Res. 18, 960\u2013969 https:\/\/doi.org\/10.1021\/acs.jproteome.8b00663 (2019).","journal-title":"J. Proteome Res."},{"key":"77320_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-6","volume":"2","author":"DA N Mustafa","year":"2014","unstructured":"N Mustafa, D. A., Swagemakers, S. M., Buise, L., van der Spek, P. J. & Kros, J. M. Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities? Acta Neuropathol. Commun. 2, 6 https:\/\/doi.org\/10.1186\/2051-5960-2-6 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"77320_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molcel.2014.05.008","volume":"55","author":"CarolineA Lewis","year":"2014","unstructured":"Lewis, C. arolineA. et al. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 55, 253\u2013263 https:\/\/doi.org\/10.1016\/j.molcel.2014.05.008 (2014).","journal-title":"Mol. Cell"},{"key":"77320_CR27","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10495-013-0877-8","volume":"18","author":"IV Mohrenz","year":"2013","unstructured":"Mohrenz, I. V. et al. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death. Apoptosis 18, 1416\u20131425 https:\/\/doi.org\/10.1007\/s10495-013-0877-8 (2013).","journal-title":"Apoptosis"},{"key":"77320_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s13277-014-2644-z","volume":"36","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumor Biol. 36, 655\u2013662 https:\/\/doi.org\/10.1007\/s13277-014-2644-z (2015).","journal-title":"Tumor Biol."},{"key":"77320_CR29","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1096\/fj.201800547R","volume":"32","author":"M Khurshed","year":"2018","unstructured":"Khurshed, M. et al. IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.  FASEB J. 32, 6344\u20136352 https:\/\/doi.org\/10.1096\/fj.201800547R (2018).","journal-title":"FASEB J."},{"key":"77320_CR30","doi-asserted-by":"publisher","unstructured":"Biedermann, J. et al. Mutant IDH1 differently affects redox state and metabolism in glial cells of normal and tumor origin. Cancers https:\/\/doi.org\/10.3390\/cancers11122028 (2019).","DOI":"10.3390\/cancers11122028"},{"key":"77320_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401\u2013410 https:\/\/doi.org\/10.1038\/nrc3262 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"77320_CR32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.1193497","volume":"330","author":"JD Rabinowitz","year":"2010","unstructured":"Rabinowitz, J. D. & White, E. Autophagy and metabolism. Science 330, 1344\u20131348 https:\/\/doi.org\/10.1126\/science.1193497 (2010).","journal-title":"Science"},{"key":"77320_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4161\/auto.24273","volume":"9","author":"AN Hale","year":"2013","unstructured":"Hale, A. N., Ledbetter, D. J., Gawriluk, T. R. & Rucker, I. I. I. E. B. Autophagy. Autophagy 9, 951\u2013972 https:\/\/doi.org\/10.4161\/auto.24273 (2013).","journal-title":"Autophagy"},{"key":"77320_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li, X., He, S. & Ma, B. Autophagy and autophagy-related proteins in cancer. Mol. Cancer 19, 12 https:\/\/doi.org\/10.1186\/s12943-020-1138-4 (2020).","journal-title":"Mol. Cancer"},{"key":"77320_CR35","first-page":"42","volume":"21","author":"BV Houten","year":"2016","unstructured":"Houten, B. V., Hunter, S. E. & Meyer, J. N. Mitochondrial DNA damage induced autophagy, cell death, and disease. FBL 21, 42\u201354 (2016).","journal-title":"FBL"},{"key":"77320_CR36","doi-asserted-by":"publisher","unstructured":"Eliopoulos, A. G., Havaki, S. & Gorgoulis, V. G. DNA damage response and autophagy: a meaningful partnership. Front. Genet. 7, 204 https:\/\/doi.org\/10.3389\/fgene.2016.00204 (2016).","DOI":"10.3389\/fgene.2016.00204"},{"key":"77320_CR37","doi-asserted-by":"publisher","unstructured":"Ianniciello, A., Rattigan, K. M. & Helgason, G. V. The ins and outs of autophagy and metabolism in hematopoietic and leukemic stem cells: food for thought. Front. Cell Dev. Biol. 6, 120 https:\/\/doi.org\/10.3389\/fcell.2018.00120 (2018).","DOI":"10.3389\/fcell.2018.00120"},{"key":"77320_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997 https:\/\/doi.org\/10.1038\/nm.3232 (2013).","journal-title":"Nat. Med."},{"key":"77320_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/auto.7.1.13044","volume":"7","author":"CD Gonzalez","year":"2011","unstructured":"Gonzalez, C. D. et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 7, 2\u201311 https:\/\/doi.org\/10.4161\/auto.7.1.13044 (2011).","journal-title":"Autophagy"},{"key":"77320_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1172\/JCI73941","volume":"125","author":"E White","year":"2015","unstructured":"White, E. The role for autophagy in cancer.  J. Clin. Investig. 125, 42\u201346 https:\/\/doi.org\/10.1172\/JCI73941 (2015).","journal-title":"J. Clin. Investig."},{"key":"77320_CR41","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41388-017-0046-6","volume":"37","author":"SS Singh","year":"2018","unstructured":"Singh, S. S. et al. Dual role of autophagy in hallmarks of cancer. Oncogene 37, 1142\u20131158 https:\/\/doi.org\/10.1038\/s41388-017-0046-6 (2018).","journal-title":"Oncogene"},{"key":"77320_CR42","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/0008-5472.CAN-17-2926","volume":"78","author":"P Viswanath","year":"2018","unstructured":"Viswanath, P. et al. 2-Hydroxyglutarate-mediated autophagy of the endoplasmic reticulum leads to an unusual downregulation of phospholipid biosynthesis in mutant IDH1 gliomas. Cancer Res. 78, 2290\u20132304 https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2926 (2018).","journal-title":"Cancer Res."},{"key":"77320_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0076-6879(08)04013-5","volume":"453","author":"H Jiang","year":"2009","unstructured":"Jiang, H., White, E. J., Conrad, C., Gomez-Manzano, C. & Fueyo, J. Autophagy pathways in glioblastoma. Methods Enzymol. 453, 273\u2013286 https:\/\/doi.org\/10.1016\/s0076-6879(08)04013-5 (2009).","journal-title":"Methods Enzymol."},{"key":"77320_CR44","doi-asserted-by":"publisher","unstructured":"Wear, D., Bhagirath, E., Balachandar, A., Vegh, C. & Pandey, S. Autophagy inhibition via hydroxychloroquine or 3-methyladenine enhances chemotherapy-induced apoptosis in neuro-blastoma and glioblastoma. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241512052 (2023).","DOI":"10.3390\/ijms241512052"},{"key":"77320_CR45","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","volume":"16","author":"MS Alghamri","year":"2022","unstructured":"Alghamri, M. S. et al. Systemic delivery of an adjuvant CXCR4\u2013CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy. ACS Nano 16, 8729\u20138750 https:\/\/doi.org\/10.1021\/acsnano.1c07492 (2022).","journal-title":"ACS Nano"},{"key":"77320_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19225-7","volume":"11","author":"JV Gregory","year":"2020","unstructured":"Gregory, J. V. et al. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy. Nat. Commun. 11, 5687 https:\/\/doi.org\/10.1038\/s41467-020-19225-7 (2020).","journal-title":"Nat. Commun."},{"key":"77320_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa088","volume":"2","author":"LE Jones","year":"2020","unstructured":"Jones, L. E. et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro Oncol. Adv. 2, vdaa088 https:\/\/doi.org\/10.1093\/noajnl\/vdaa088 (2020).","journal-title":"Neuro Oncol. Adv."},{"key":"77320_CR48","doi-asserted-by":"publisher","unstructured":"Grasso, D., Renna, F. J. & Vaccaro, M. I. Initial steps in mammalian autophagosome biogenesis. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2018.00146 (2018).","DOI":"10.3389\/fcell.2018.00146"},{"key":"77320_CR49","doi-asserted-by":"crossref","unstructured":"Di Malta, C., Cinque, L. & Settembre, C. Transcriptional regulation of autophagy: mechanisms and diseases. Front. Cell Dev. Biol. 7, (2019).","DOI":"10.3389\/fcell.2019.00114"},{"key":"77320_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature10866","volume":"483","author":"S Turcan","year":"2012","unstructured":"Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479\u2013483 https:\/\/doi.org\/10.1038\/nature10866 (2012).","journal-title":"Nature"},{"key":"77320_CR51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1101\/gad.217406.113","volume":"27","author":"JA Losman","year":"2013","unstructured":"Losman, J. A. & Kaelin, W. G. Jr. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27, 836\u2013852 https:\/\/doi.org\/10.1101\/gad.217406.113 (2013). From NLM.","journal-title":"Genes Dev."},{"key":"77320_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","volume":"175","author":"SK McBrayer","year":"2018","unstructured":"McBrayer, S. K. et al. Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell 175, 101\u2013116.e125 https:\/\/doi.org\/10.1016\/j.cell.2018.08.038 (2018).","journal-title":"Cell"},{"key":"77320_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"S Zhao","year":"2009","unstructured":"Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1\u03b1. Science 324, 261\u2013265 https:\/\/doi.org\/10.1126\/science.1170944 (2009).","journal-title":"Science"},{"key":"77320_CR54","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ccell.2017.11.005","volume":"32","author":"T Huang","year":"2017","unstructured":"Huang, T. et al. MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radioresistance in glioblastoma. Cancer Cell 32, 840\u2013855.e848 https:\/\/doi.org\/10.1016\/j.ccell.2017.11.005 (2017).","journal-title":"Cancer Cell"},{"key":"77320_CR55","doi-asserted-by":"crossref","unstructured":"Tanida, I., Ueno, T. & Kominami, E. LC3 and autophagy. In Autophagosome and Phagosome (ed. Deretic, V.) 77\u201388 (Humana Press, 2008).","DOI":"10.1007\/978-1-59745-157-4_4"},{"key":"77320_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-020-0141-7","volume":"6","author":"WW-Y Yim","year":"2020","unstructured":"Yim, W. W.-Y. & Mizushima, N. Lysosome biology in autophagy. Cell Discov. 6, 6 https:\/\/doi.org\/10.1038\/s41421-020-0141-7 (2020).","journal-title":"Cell Discov."},{"key":"77320_CR57","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1126\/science.aag3048","volume":"359","author":"DS Leeman","year":"2018","unstructured":"Leeman, D. S. et al. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science 359, 1277\u20131283 https:\/\/doi.org\/10.1126\/science.aag3048 (2018).","journal-title":"Science"},{"key":"77320_CR58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.radonc.2011.06.002","volume":"99","author":"H Chaachouay","year":"2011","unstructured":"Chaachouay, H. et al. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother. Oncol. 99, 287\u2013292 https:\/\/doi.org\/10.1016\/j.radonc.2011.06.002 (2011).","journal-title":"Radiother. Oncol."},{"key":"77320_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/neup.12535","volume":"39","author":"K Masui","year":"2019","unstructured":"Masui, K., Onizuka, H., Cavenee, W. K., Mischel, P. S. & Shibata, N. Metabolic reprogramming in the pathogenesis of glioma: Update. Neuropathology 39, 3\u201313 https:\/\/doi.org\/10.1111\/neup.12535 (2019).","journal-title":"Neuropathology"},{"key":"77320_CR60","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/0008-5472.CAN-14-0772-T","volume":"74","author":"AR Grassian","year":"2014","unstructured":"Grassian, A. R. et al. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res. 74 3317\u20133331, https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0772-T (2014).","journal-title":"Cancer Res."},{"key":"77320_CR61","doi-asserted-by":"publisher","unstructured":"Fack, F. et al. Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Mol. Med. 9, 1681\u20131695 https:\/\/doi.org\/10.15252\/emmm.201707729 (2017).","DOI":"10.15252\/emmm.201707729"},{"key":"77320_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00984-9","volume":"8","author":"G Karpel-Massler","year":"2017","unstructured":"Karpel-Massler, G. et al. Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL. Nat. Commun. 8, 1067 https:\/\/doi.org\/10.1038\/s41467-017-00984-9 (2017).","journal-title":"Nat. Commun."},{"key":"77320_CR63","doi-asserted-by":"publisher","unstructured":"L\u00f3pez de Figueroa, P., Lotz, M. K., Blanco, F. J. & Caram\u00e9s, B. Autophagy activation and protection from mitochondrial dysfunction in human chondrocytes. Arthritis Rheumatol. 67, 966\u2013976 https:\/\/doi.org\/10.1002\/art.39025 (2015).","DOI":"10.1002\/art.39025"},{"key":"77320_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gendis.2015.12.002","volume":"3","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Mitochondrial dysfunction activates the AMPK signaling and autophagy to promote cell survival. Genes Dis. 3, 82\u201387 https:\/\/doi.org\/10.1016\/j.gendis.2015.12.002 (2016).","journal-title":"Genes Dis."},{"key":"77320_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96092-2","volume":"11","author":"DH Youn","year":"2021","unstructured":"Youn, D. H. et al. Mitochondrial dysfunction associated with autophagy and mitophagy in cerebrospinal fluid cells of patients with delayed cerebral ischemia following subarachnoid hemorrhage. Sci. Rep. 11, 16512 https:\/\/doi.org\/10.1038\/s41598-021-96092-2 (2021).","journal-title":"Sci. Rep."},{"key":"77320_CR66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213670120","volume":"120","author":"Y Lin","year":"2023","unstructured":"Lin, Y. et al. A small-molecule drug inhibits autophagy gene expression through the central regulator TFEB. Proc. Natl. Acad. Sci. USA 120, e2213670120 https:\/\/doi.org\/10.1073\/pnas.2213670120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77320_CR67","doi-asserted-by":"publisher","unstructured":"Tang, A. H. & Rando, T. A. Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J. 33, 2782\u20132797 https:\/\/doi.org\/10.15252\/embj.201488278 (2014).","DOI":"10.15252\/embj.201488278"},{"key":"77320_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109528","volume":"36","author":"L Poillet-Perez","year":"2021","unstructured":"Poillet-Perez, L., Sarry, J.-E. & Joffre, C. Autophagy is a major metabolic regulator involved in cancer therapy resistance. Cell Rep. 36, 109528 https:\/\/doi.org\/10.1016\/j.celrep.2021.109528 (2021).","journal-title":"Cell Rep."},{"key":"77320_CR69","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2001017","volume":"3","author":"Q-W Fan","year":"2010","unstructured":"Fan, Q.-W. et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci. Signal. 3, ra81 https:\/\/doi.org\/10.1126\/scisignal.2001017 (2010).","journal-title":"Sci. Signal."},{"key":"77320_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-016-0303-5","volume":"35","author":"Y Yan","year":"2016","unstructured":"Yan, Y. et al. Targeting autophagy to sensitive glioma to temozolomide treatment. J. Exp. Clin. Cancer Res. 35, 23 https:\/\/doi.org\/10.1186\/s13046-016-0303-5 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77320_CR71","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1124\/jpet.112.199802","volume":"344","author":"ML Bristol","year":"2013","unstructured":"Bristol, M. L. et al. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J. Pharmacol. Exp. Ther. 344, 544 https:\/\/doi.org\/10.1124\/jpet.112.199802 (2013).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"77320_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102043","volume":"88","author":"L Mele","year":"2020","unstructured":"Mele, L. et al. The role of autophagy in resistance to targeted therapies. Cancer Treat. Rev. 88, 102043 https:\/\/doi.org\/10.1016\/j.ctrv.2020.102043 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"77320_CR73","doi-asserted-by":"publisher","unstructured":"Escamilla-Ram\u00edrez, A. et al. Autophagy as a potential therapy for malignant glioma. Pharmaceuticals https:\/\/doi.org\/10.3390\/ph13070156 (2013).","DOI":"10.3390\/ph13070156"},{"key":"77320_CR74","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1101\/gad.1545107","volume":"21","author":"R Mathew","year":"2007","unstructured":"Mathew, R. et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 21, 1367\u20131381 https:\/\/doi.org\/10.1101\/gad.1545107 (2007).","journal-title":"Genes Dev."},{"key":"77320_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12094-9","volume":"10","author":"SG Holdgaard","year":"2019","unstructured":"Holdgaard, S. G. et al. Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites. Nat. Commun. 10, 4176 https:\/\/doi.org\/10.1038\/s41467-019-12094-9 (2019).","journal-title":"Nat. Commun."},{"key":"77320_CR76","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.4161\/auto.21035","volume":"8","author":"Z Zhao","year":"2012","unstructured":"Zhao, Z. et al. UVRAG: at the crossroad of autophagy and genomic stability. Autophagy 8, 1392\u20131393 https:\/\/doi.org\/10.4161\/auto.21035 (2012).","journal-title":"Autophagy"},{"key":"77320_CR77","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/embor.2008.163","volume":"9","author":"J Geng","year":"2008","unstructured":"Geng, J. & Klionsky, D. J. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. \u2018Protein modifications: beyond the usual suspects\u2019 review series. EMBO Rep. 9, 859\u2013864 https:\/\/doi.org\/10.1038\/embor.2008.163 (2008).","journal-title":"EMBO Rep."},{"key":"77320_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1042\/bst20210819","volume":"50","author":"Y Hu","year":"2022","unstructured":"Hu, Y. & Reggiori, F. Molecular regulation of autophagosome formation. Biochem Soc. Trans. 50, 55\u201369 https:\/\/doi.org\/10.1042\/bst20210819 (2022).","journal-title":"Biochem Soc. Trans."},{"key":"77320_CR79","doi-asserted-by":"publisher","unstructured":"Yin, Z., Popelka, H., Lei, Y., Yang, Y. & Klionsky, D. J. The roles of ubiquitin in mediating autophagy. Cells https:\/\/doi.org\/10.3390\/cells9092025 (2020).","DOI":"10.3390\/cells9092025"},{"key":"77320_CR80","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1158\/1078-0432.CCR-19-3714","volume":"26","author":"F Mendez","year":"2020","unstructured":"Mendez, F. et al. Therapeutic efficacy of immune stimulatory thymidine kinase and fms-like tyrosine kinase 3 ligand (TK\/Flt3L) gene therapy in a mouse model of high-grade brainstem glioma. Clin. Cancer Res. 26, 4080\u20134092 https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3714 (2020).","journal-title":"Clin. Cancer Res."},{"key":"77320_CR81","doi-asserted-by":"publisher","unstructured":"Drumm, M. R. et al. Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci168035 (2023).","DOI":"10.1172\/jci168035"},{"key":"77320_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58911-2","volume":"16","author":"U Sahu","year":"2025","unstructured":"Sahu, U. et al. IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity. Nat. Commun. 16, 3874 https:\/\/doi.org\/10.1038\/s41467-025-58911-2 (2025).","journal-title":"Nat. Commun."},{"key":"77320_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33943-0","volume":"13","author":"SD Muthukrishnan","year":"2022","unstructured":"Muthukrishnan, S. D. et al. P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cells. Nat. Commun. 13, 6202 https:\/\/doi.org\/10.1038\/s41467-022-33943-0 (2022).","journal-title":"Nat. Commun."},{"key":"77320_CR84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403862122","volume":"122","author":"N Furth","year":"2025","unstructured":"Furth, N. et al. Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneity. Proc. Natl. Acad. Sci. USA 122, e2403862122 https:\/\/doi.org\/10.1073\/pnas.2403862122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77320_CR85","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jmri.28743","volume":"58","author":"YW Park","year":"2023","unstructured":"Park, Y. W. et al. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas. J. Magn. Reson Imaging 58, 677\u2013689 https:\/\/doi.org\/10.1002\/jmri.28743 (2023).","journal-title":"J. Magn. Reson Imaging"},{"key":"77320_CR86","doi-asserted-by":"publisher","DOI":"10.3791\/52443","author":"AA Calinescu","year":"2015","unstructured":"Calinescu, A. A. et al. Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52443 (2015).","journal-title":"J. Vis. Exp."},{"key":"77320_CR87","doi-asserted-by":"publisher","unstructured":"Koschmann, C. et al. ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Sci. Transl. Med.8, 328ra328 https:\/\/doi.org\/10.1126\/scitranslmed.aac8228 (2016).","DOI":"10.1126\/scitranslmed.aac8228"},{"key":"77320_CR88","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3052","volume":"20","author":"H Wakimoto","year":"2014","unstructured":"Wakimoto, H. et al. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clin. Cancer Res. 20, 2898\u20132909 https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3052 (2014).","journal-title":"Clin. Cancer Res."},{"key":"77320_CR89","doi-asserted-by":"publisher","unstructured":"Tripathy, A. et al. Precision oncology for high-grade gliomas: a tumor organoid model for adjuvant treatment selection. Bioengineering https:\/\/doi.org\/10.3390\/bioengineering12101121 (2025).","DOI":"10.3390\/bioengineering12101121"},{"key":"77320_CR90","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77320_CR91","doi-asserted-by":"crossref","unstructured":"Efron, B. & Tibshirani, R. On testing the significance of sets of genes. Ann. Appl. Stat. 1, 107\u2013129. (2007).","DOI":"10.1214\/07-AOAS101"},{"key":"77320_CR92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymeth.2013.08.015","volume":"67","author":"MT Paulsen","year":"2014","unstructured":"Paulsen, M. T. et al. Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA. Methods 67, 45\u201354, https:\/\/doi.org\/10.1016\/j.ymeth.2013.08.015 (2014).","journal-title":"Methods"},{"key":"77320_CR93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 https:\/\/doi.org\/10.1038\/nmeth.1923 (2012).","journal-title":"Nat. Methods"},{"key":"77320_CR94","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165, https:\/\/doi.org\/10.1093\/nar\/gkw257 (2016).","journal-title":"Nucleic Acids Res."},{"key":"77320_CR95","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1093\/bioinformatics\/btu372","volume":"30","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Lin, Y. H., Johnson, T. D., Rozek, L. S. & Sartor, M. A. PePr: a peak-calling prioritization pipeline to identify consistent or differential peaks from replicated ChIP-Seq data. Bioinformatics 30, 2568\u20132575 https:\/\/doi.org\/10.1093\/bioinformatics\/btu372 (2014).","journal-title":"Bioinformatics"},{"key":"77320_CR96","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/bioinformatics\/btx183","volume":"33","author":"RG Cavalcante","year":"2017","unstructured":"Cavalcante, R. G. & Sartor, M. A. annotatr: genomic regions in context. Bioinformatics 33, 2381\u20132383 https:\/\/doi.org\/10.1093\/bioinformatics\/btx183 (2017).","journal-title":"Bioinformatics"},{"key":"77320_CR97","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1093\/nar\/gku463","volume":"42","author":"RP Welch","year":"2014","unstructured":"Welch, R. P. et al. ChIP-Enrich: gene set enrichment testing for ChIP-seq data. Nucleic Acids Res. 42, e105 https:\/\/doi.org\/10.1093\/nar\/gku463 (2014).","journal-title":"Nucleic Acids Res."},{"key":"77320_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"key":"77320_CR99","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/pbc.22801","volume":"56","author":"MH Kang","year":"2011","unstructured":"Kang, M. H. et al. National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing. Pediatr. Blood Cancer 56, 239\u2013249 https:\/\/doi.org\/10.1002\/pbc.22801 (2011).","journal-title":"Pediatr. Blood Cancer"},{"key":"77320_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-019-0202-2","volume":"8","author":"BS Nelson","year":"2020","unstructured":"Nelson, B. S. et al. Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy. Cancer Metab. 8, 1 https:\/\/doi.org\/10.1186\/s40170-019-0202-2 (2020).","journal-title":"Cancer Metab."},{"key":"77320_CR101","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3762\/bjnano.13.22","volume":"13","author":"N Habibi","year":"2022","unstructured":"Habibi, N., Mauser, A., Raymond, J. E. & Lahann, J. Systematic studies into uniform synthetic protein nanoparticles. Beilstein J. Nanotechnol. 13, 274\u2013283 https:\/\/doi.org\/10.3762\/bjnano.13.22 (2022).","journal-title":"Beilstein J. Nanotechnol."},{"key":"77320_CR102","doi-asserted-by":"publisher","first-page":"e1000010","DOI":"10.1371\/journal.pmed.1000010","volume":"6","author":"JF Curtin","year":"2009","unstructured":"Curtin, J. F. et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 6, e1000010 https:\/\/doi.org\/10.1371\/journal.pmed.1000010 (2009).","journal-title":"PLoS Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77320-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:03:18Z","timestamp":1789722198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77320-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77320"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77320-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past three years, C.A.L. has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures, and T-Knife Therapeutics, and is an inventor on patents pertaining to Kras regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-ME1 pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05\/07\/2015; US Patent No: 20190136238, 05\/09\/2019; International Patent No: WO2013177426-A2, 04\/23\/2015). All other authors declare that there is no conflict of interest regarding the publication of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9740"}}